The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis.

Hong Shen,Rui Min,Qi Tan,Weiping Xie,Wang H,Hongqiu Pan,Li Zhang,Hongtao Xu,Xia Zhang,Jianzhong Dai

The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis.

2015

Hong Shen
Rui Min
Qi Tan
Weiping Xie
Wang H
Hongqiu Pan
Li Zhang
Hongtao Xu
Xia Zhang
Jianzhong Dai

Introduction Multidrug-resistant tuberculosis (MDR-TB) is a hard-to-treat disease with a poor outcome of chemotherapy. In the present study, the efficacy and safety of recombinant human interleukin-2 (rhIL-2) were investigated in patients with MDR-TB.

Keywords:

Diabetes mellitus
Medicine
Disease
Immunotherapy
Pharmacology
Multiple drug resistance
Recombinant DNA
Chemotherapy
Interleukin 2
Tuberculosis
Internal medicine
T cell
Regimen
IL-2 receptor
Cardiology
Sputum

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations